Washington, D.C., August 31, 2023 — The Society of Vascular and Interventional Neurology (SVIN) and its Mission Thrombectomy Committee (SVIN_MT) proudly announce a momentous achievement. On August 8, 2023, the esteemed United Nations Economic and Social Council (ECOSOC) granted SVIN the prestigious special consultative status.

SVIN is thrilled to herald a new chapter in its journey, what it means for its members and affiliations, to advance global conversations and patient access to thrombectomy. It positions SVIN at the forefront of organizations collaborating with ECOSOC, opening doors to impactful interactions with subsidiary bodies, including the Human Rights Council. Moreover, this status facilitates participation in select General Assembly meetings and other intergovernmental gatherings, fostering collaborative exchanges with the United Nations Secretariat.

This status underscores SVIN's dedication to making a tangible difference on a global scale, opening the doors to impactful dialogues, critical collaborations, and valuable partnerships that align with SVIN's mission to advance vascular and interventional neurology for the betterment of global healthcare.

Read More: https://www.svin.org/i4a/headlines/headlinedetails.cfmcontroller=headlines&action=headlineDetails&id=86&categoryID=0&startVal=1

Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the USA—has been named the 2023 president of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery.

As president, Jayaraman will lead the SNIS in all its endeavours to enhance the field, according to a press release. SNIS members work to promote research, standard-setting, education and advocacy regarding diagnosing and treating diseases of the brain, spine, head, and neck. With more than 1,000 members worldwide, the society is committed to providing the highest quality of patient care through these minimally invasive procedures, the release adds.

Read More: https://neuronewsinternational.com/mahesh-jayaraman-becomes-28th-president-of-the-society-of-neurointerventional-surgery/

 Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Lucas Buchanan has been appointed to the Endologix Board of Directors.

Lucas Buchanan is currently the Chief Financial Officer and Chief Operating Officer at Silk Road Medical, Inc. He is widely recognized for his contributions to Silk Road Medical as the company introduced a new therapy for the treatment of carotid artery stenosis and changed the paradigm for patients with cerebrovascular disease. Mr. Buchanan played a pivotal role in financing the company and scaling its operations, including leading Silk Road’s initial public offering in 2019, and his role has continued to expand. Prior to Silk Road Medical, Mr. Buchanan’s background includes investing, business development, and operating roles at The Vertical Group, Impax Laboratories, Medtronic, and Ernst & Young. He holds an MBA in Health Care Management from The Wharton School at the University of Pennsylvania and a BA in Economics from Duke University.

Read More: https://endologix.com/news/endologix-announces-that-lucas-buchanan-joins-board-of-directors/

John Davis’ resume includes serving as a test engineer of radar systems on the Apollo modules that went to the moon. Click to listen.

Read More: ​https://www.reviewjournal.com/livewell/it-can-kill-you-retiree-urges-awareness-of-carotid-artery-disease-2890000/

A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than two hours to be transferred to a comprehensive stroke center (CSC)—a treatment delay that creates an increased risk of long-term disability.

“In neurology, we often say that ‘time is brain’,” said Shyam Prabhakaran (University of Chicago, Chicago, USA), senior author on the study, which has been published in the Journal of the American Medical Association (JAMA). “For every 15 minutes that pass without treatment, prior research shows there is a steady decrease in the chances of good outcomes for stroke patients. Getting to the right hospital quickly can be lifesaving.”

Analysing recent data from over 100,000 patients at 1,925 hospitals across the USA, the researchers found that the median time between initial arrival and departure for transfer—known as door-in-door-out (DIDO) time—was 174 minutes, with almost three in four patients waiting longer than the recommended maximum of 120 minutes.

Read More: ​https://neuronewsinternational.com/us-registry-study-reveals-75-of-acute-stroke-patients-wait-more-than-two-hours-for-csc-transfer/